Cross-border paid plasma donation among injection drug users in two Mexico-U.S. border cities

International Journal of Drug Policy

Volumn 20, Issue 5, 2009, Pages 409-412

  Volkow, Patricia ^a   Brouwer, Kimberly C ^b   Loza, Oralia ^b   Ramos, Rebeca ^c   Lozada, Remedios ^d   Garfein, Richard S ^b   Magis Rodriguez, Carlos ^e   Firestone Cruz, Michelle ^b   Strathdee, Steffanie A ^b  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c United States Mexico Border Health Association   (United States)

^d Patronato Pro COMUSIDA   (Mexico)

^e SECRETARÍA DE SALUD   (Mexico)

Author keywords

Blood trade; HIV; Injection drug use; Mexico; Plasma center; Plasmapheresis

Indexed keywords

ADULT; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; FEMALE; HEPATITIS C; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MEXICO; PREVALENCE; PRIORITY JOURNAL; UNITED STATES;

ADULT; BLOOD DONORS; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; MEXICO; PLASMAPHERESIS; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES;

EID: 67651062130     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2008.12.006     Document Type: Article

References (32)

1. Alvarez-Suarez Y., Marin-Lopez A., Lobato-Mendizabal E., and Galindo-Rodriguez C. Paid blood donors: a new risk group for the development of AIDS in Mexico. Salud Publica De Mexico 31 5 (1989) 642-644
2. Anonymous. Outbreak of hepatitis C associated with intravenous immunoglobulin administration-United States, October 1993-June 1994. MMWR 43 28 (1994) 505-509
3. Avila C., Stetler H.C., Sepulveda J., Dickinson E., Castro K.G., Ward J.W., et al. The epidemiology of HIV transmission among paid plasma donors, Mexico City, Mexico. AIDS 3 10 (1989) 631-633
4. Blumel J., Schmidt I., Effenberger W., Seitz H., Willkommen H., Brackmann H.H., et al. Parvovirus B19 transmission by heat-treated clotting factor concentrates. Transfusion 42 11 (2002) 1473-1481
5. Bresee J.S., Mast E.E., Coleman P.J., Baron M.J., Schonberger L.B., Alter M.J., et al. Hepatitis C virus infection associated with administration of intravenous immune globulin. A cohort study. JAMA 276 19 (1996) 1563-1567
6. Bucardo J., Brouwer K.C., Magis-Rodriguez C., Ramos R., Fraga M., Perez S.G., et al. Historical trends in the production and consumption of illicit drugs in Mexico: Implications for the prevention of blood borne infections. Drug and Alcohol Dependence 79 3 (2005) 281-293
7. Craske J., Kirk P., Cohen B., and Vandervelde E.M. Commercial factor VIII associated hepatitis, 1974-1975, in the United Kingdom: A retrospective survey. Journal of Hygiene (London) 80 3 (1978) 327-336
8. Echevarria J.M., Leon P., Domingo C.J., Lopez J.A., Elola C., Madurga M., et al. Laboratory diagnosis and molecular epidemiology of an outbreak of hepatitis C virus infection among recipients of human intravenous immunoglobulin in Spain. Transfusion 36 8 (1996) 725-730
9. Frost S.D., Brouwer K.C., Firestone Cruz M.A., Ramos R., Ramos M.E., Lozada R.M., et al. Respondent-driven sampling of injection drug users in two U.S.-Mexico border cities: Recruitment dynamics and impact on estimates of HIV and syphilis prevalence. Journal of Urban Health 83 6 Suppl (2006) i83-i97
10. Goedert J.J., Sarngadharan M.G., Eyster M.E., Weiss S.H., Bodner A.J., Gallo R.C., et al. Antibodies reactive with human T cell leukemia viruses in the serum of hemophiliacs receiving factor VIII concentrate. Blood 65 2 (1985) 492-495
11. Heckathorn D. Respondent-driven sampling II: Deriving valid population estimates from chain-referral samples of hidden populations. Social Problems 49 1 (2002) 11-34
12. INEGI (2000). (Instituto Nacional de Estadistica Geografia e Informatica) (2000) Resultados Preliminares de XII Censo Nacional de Poblacion y Vivienda 2000. (Preliminary Results for the XII National Population and Housing Census-2000) Press Release June 21.
13. James R.C., and Mustard C.A. Geographic location of commercial plasma donation clinics in the United States, 1980-1995. American Journal of Public Health 94 7 (2004) 1224-1229
14. Jee Y.M., Go U., Cheon D., Kang Y., Yoon J.D., Lee S.W., et al. Detection of hepatitis A virus from clotting factors implicated as a source of HAV infection among haemophilia patients in Korea. Epidemiology and Infection 134 1 (2006) 87-93
15. John T.J., Ninan G.T., Rajagopalan M.S., John F., Flewett T.H., Francis D.P., et al. Epidemic hepatitis B caused by commercial human immunoglobulin. Lancet 1 8125 (1979) 1074
16. Johnson Z., Thornton L., Tobin A., Lawlor E., Power J., Hillary I., et al. An outbreak of hepatitis A among Irish haemophiliacs. International Journal of Epidemiology 24 4 (1995) 821-828
17. Kleim J.P., Bailly E., Schneweis K.E., Brackmann H.H., Hammerstein U., Hanfland P., et al. Acute HIV-1 infection in patients with hemophilia B treated with beta-propiolactone-UV-inactivated clotting factor. Thrombosis and Haemostasis 64 2 (1990) 336-337
18. Koerper M.A., Kaminsky L.S., and Levy J.A. Differential prevalence of antibody to AIDS-associated retrovirus in haemophiliacs treated with Factor VIII concentrate versus cryoprecipitate: Recovery of infectious virus. Lancet 1 8423 (1985) 275
19. Kupfer B., Oldenburg J., Brackmann H.H., Matz B., Schneweis K.E., and Kaiser R. Beta-propiolactone UV inactivated clotting factor concentrate is the source of HIV-infection of 8 hemophilia B patients: Confirmed. Thrombosis and Haemostasis 74 5 (1995) 1386-1387
20. Lawlor E., Power J., Garson J., Yap P., Davidson F., Columb G., et al. Transmission rates of hepatitis C virus by different batches of a contaminated anti-D immunoglobulin preparation. Vox Sanguinis 76 3 (1999) 138-143
21. Lefrere J.J., Loiseau P., Martinot-Peignoux M., Mariotti M., Ravera N., Thauvin M., et al. Infection by hepatitis C virus through contaminated intravenous immune globulin: Results of a prospective national inquiry in France. Transfusion 36 5 (1996) 394-397
22. Machin S.J., McVerry B.A., Cheingsong-Popov R., and Tedder R.S. Seroconversion for HTLV-III since 1980 in British haemophiliacs. Lancet 1 8424 (1985) 336
23. Madhok R., Melbye M., Lowe G.D., Forbes C.D., Froebel K.S., Bodner A.J., et al. HTLV-III antibody in sequential plasma samples: From haemophiliacs 1974-84. Lancet 1 8427 (1985) 524-525
24. Mannucci P.M., Gdovin S., Gringeri A., Colombo M., Mele A., Schinaia N., et al., The Italian Collaborative Group. Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. Annals of Internal Medicine 120 1 (1994) 1-7
25. Mathez D., Leibovitch J., Sultan Y., and Maisonneuve P. LAV/HTLV-III seroconversion and disease in hemophiliacs treated in France. New England Journal of Medicine 314 2 (1986) 118-119
26. Melbye M., Froebel K.S., Madhok R., Biggar R.J., Sarin P.S., Stenbjerg S., et al. HTLV-III seropositivity in European haemophiliacs exposed to Factor VIII concentrate imported from the USA. Lancet 2 8417-8418 (1984) 1444-1446
27. Ragni M.V., Tegtmeier G.E., Levy J.A., Kaminsky L.S., Lewis J.H., Spero J.A., et al. AIDS retrovirus antibodies in hemophiliacs treated with factor VIII or factor IX concentrates, cryoprecipitate, or fresh frozen plasma: Prevalence, seroconversion rate, and clinical correlations. Blood 67 3 (1986) 592-595
28. Sepulveda Amor J., de Lourdes Garcia M., Dominguez Torix J.L., and Valdespino Gomez J.L. Prevention of HIV transmission through blood and blood products: Experiences in Mexico. Bulletin of the Pan American Health Organization 23 1-2 (1989) 108-114
29. Soucie J.M., Siwak E.B., Hooper W.C., Evatt B.L., and Hollinger F.B. Human parvovirus B19 in young male patients with hemophilia A: Associations with treatment product exposure and joint range-of-motion limitation. Transfusion 44 8 (2004) 1179-1185
30. Strathdee S.A., and Magis-Rodriguez C. Mexico's evolving HIV epidemic. JAMA 300 5 (2008) 571-573
31. Verani P., Mariani G., Mannucci P.M., De Rossi G., Nicoletti L., Titti F., et al. Prevalence of HTLV-III/LAV antibodies in Italian asymptomatic hemophiliacs given commercial concentrates of factors VIII and IX. Journal of Medical Virology 19 2 (1986) 143-149
32. Volkow P., and Del Rio C. Paid donation and plasma trade: unrecognized forces that drive the AIDS epidemic in developing countries. International Journal of STD & AIDS 16 1 (2005) 5-8